Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-17-005712
Filing Date
2017-05-22
Accepted
2017-05-22 17:07:51
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO ANNUAL REPORT f10k2016a2_americanbrivision.htm 10-K/A 862475
2 CERTIFICATION f10k2016a2ex31i_americanbri.htm EX-31.1 11739
3 CERTIFICATION f10k2016a2ex31ii_americanbri.htm EX-31.2 11742
4 CERTIFICATION f10k2016a2ex32i_americanbri.htm EX-32.1 4334
5 CERTIFICATION f10k2016a2ex32ii_americanbri.htm EX-32.2 4511
  Complete submission text file 0001213900-17-005712.txt   2802938

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE mtoo-20160930.xml EX-101.INS 342637
7 XBRL SCHEMA FILE mtoo-20160930.xsd EX-101.SCH 29533
8 XBRL CALCULATION FILE mtoo-20160930_cal.xml EX-101.CAL 26936
9 XBRL DEFINITION FILE mtoo-20160930_def.xml EX-101.DEF 76097
10 XBRL LABEL FILE mtoo-20160930_lab.xml EX-101.LAB 206877
11 XBRL PRESENTATION FILE mtoo-20160930_pre.xml EX-101.PRE 167793
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-91436 | Film No.: 17861728
SIC: 2834 Pharmaceutical Preparations